Skip to content

A randomized controlled clinical trial on Wet cupping therapy in the management of Primary Hypertension

A randomized controlled clinical trial on Hijama bil shart (Wet cupping therapy) in the management of Zaghtuddam Qawi Ibtedai (Primary Hypertension) - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/03/081563
Enrollment
60
Registered
2025-03-03
Start date
Unknown
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I10- Essential (primary) hypertension

Interventions

Intervention1: Hijama bil shart, Qurs dawa-ul-shifa and Riyazat with dietary restrictions.: Route of Administration &dose of drug: Orally 2 tablets with water once a day for 5 weeks. Riyazat: Brisk w

Sponsors

Shibra Farooq
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Grade 1 hypertension patients ( SBP 140mm -159mmHg and DBP 90mmHg - 99mmHg). 2 Firstly, diagnosed cases of hypertension, or the cases who are not on hypertensive medication. 3 Age between 20 and 60 years old. 4 Hb% 10gm/dl or more. 5 Both genders. 6 Patients willing to take part in the study.

Exclusion criteria

Exclusion criteria: • Grade 2,3 hypertension (SBP 159mmHg or more and DBP 99mmHg BP or more). • Excluding patients who have associated clinical conditions which are: cerebro vascular disease, heart disease, renal disease, peripheral vascular disease, and advanced retinopathy. • Patients suffering from psychiatric disorder. • Patients with generalized skin infection. • Patients with blood disorders like hemophilia, thrombocytopenia, etc. • Patients with secondary hypertension. • Pregnant women & lactating mothers. • Patients who fail to give consent for the trial and follow up.

Design outcomes

Primary

MeasureTime frame
Systolic blood pressure more than or equal to 130 mmHg and diastolic blood pressure more than 80 mmHgTimepoint: 0, 7th, 14th, 21st, 28th day

Secondary

MeasureTime frame
WHOQOL-BREF QuestionnaireTimepoint: 0, 7th, 14th, 21st, 28th day

Countries

India

Contacts

Public ContactShibra Farooq
drmsaad.ib@amu.ac.in9412595931

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026